Keynote/Invited Speakers

The Conference Convenors and Program Committee are working to develop a program that will feature a range of engaging keynote and invited speakers. Watch this space for the latest speaker updates and information!

Keynote Speakers

Heather D’Antoine

Division Leader of Education and Capacity Building and Associate Director for Aboriginal Programs, Menzies School of Health Research

Heather has 25 years of experience in health services as a registered nurse and midwife and as a health service manager in both Aboriginal health services and general health services across Western Australia. In the last 12 years, Heather has worked in health research: eight years at the Institute for Child Health Research and two years at the Menzies School of Health Research. She has clinical qualifications in general nursing and midwifery and academic qualifications in health economics. Heather’s research interest is in maternal and child health. She is particularly focused on the area of fetal alcohol spectrum disorders (FASD) and other birth defects. Heather has worked with a research team on a number of projects in this area including describing what health professionals and women know and do about alcohol and pregnancy and FASD. She has been involved with developing and evaluating resources for health professionals and developing a model of care for FASD in Western Australia.

Catherine Wood

Chief Executive Officer/Chief Investment Officer, ARK Invest

Cathie registered ARK Investment Management LLC (“ARK”) as an investment adviser with the U.S. Securities and Exchange Commission in January 2014. Focused solely on disruptive innovation, ARK aims to identify large-scale investment opportunities in the public markets resulting from technological innovations centered around genome sequencing, robotics, artificial intelligence, energy storage, and blockchain technology. Prior to ARK, Cathie spent twelve years at AllianceBernstein as Chief Investment Officer of Global Thematic Strategies where she managed over $5 billion. Cathie joined Alliance Capital from Tupelo Capital Management, a hedge fund she co-founded which, in 2000, managed $800 million in global thematic strategies. Prior to her tenure at Tupelo Capital, she worked for 18 years with Jennison Associates as Chief Economist, Equity Research Analyst, Portfolio Manager and Director. She started her career in Los Angeles, California at The Capital Group as an Assistant Economist. Cathie received her Bachelor of Science, summa cum laude, in Finance and Economics from the University of Southern California in 1981. In 2018, editors at Bloomberg acknowledged Cathie by selecting her to its second annual Bloomberg 50 list of people across business, entertainment, finance, politics, technology, and science who have defined global business. Additionally, Fortune named Cathie to its exclusive roundtable of experts in the annual Fortune Investors Guide: The Best Investing Advice for 2019 From Fortune’s Experts. In 2016, Cathie received the “Women in Finance – Outstanding Contribution Award” from Market Media, and she was a featured speaker at the World Economic Forum (China) in 2016 & 2017, and the World Strategic Forum (Miami) in 2017.

Sue MacLeman

Chair and Non-Executive Director, MTPConnect

Sue MacLeman has more than 30 years’ experience as a pharmaceutical, biotechnology and medical technology executive having held senior roles in corporate, medical, commercial and business development. Sue has also served as CEO and Board member of several ASX and NASDAQ listed companies in the pharmaceutical sector and is currently Chair of MTPConnect (MTPII-GC Ltd), Chair of Anatara Lifesciences Ltd (ASX:ANR), Chair of Novita Healthcare Ltd (ASX:NHL), Non-Executive Director of TPI Enterprises Ltd (ASX:TPE), Non-Executive Director of Oventus Medical Ltd (ASX:OVN) and Non-Executive Director of veski. Sue is also appointed to several academic and government advisory committees.

Professor Lisa Bero PhD

Chair of Medicines Use and Health Outcomes, Charles Perkins Centre, The University of Sydney

Lisa A. Bero, PhD is an expert in examining how science can be influenced and translated into clinical practice and health policy.  She directs the Evidence, Policy and Influence Collaborative Research Program at the Charles Perkins Centre, with Research nodes in Bias, Evidence Synthesis and Pharmaceutical Policy.  Professor Bero is Chair of Medicines Use and Health Outcomes, Faculty of Medicine and Health, School of Pharmacy, The University of Sydney.  She was Co-Chair, The Cochrane Collaboration, from 2014-2018.  She has developed and validated methods for assessing bias in the design, conduct and dissemination of research on pharmaceuticals, tobacco, chemicals, and complex public health interventions.  Prof. Bero has also conducted analyses to examine the dissemination and policy implications of research evidence.  Her international activities include member and chair of the World Health Organization (WHO) Essential Medicines Committee and Cochrane Collaboration liaison to WHO.  Prof. Bero serves on several committees related to conflicts of interest, evidence and decisions, such as the Institute of Medicine Committee on Conflict of Interest in Medical Research, Education and Practice and the National Academy of Science Committee to review the Environmental Protection Agency Integrated Risk Information System Process.

Dr Andy Cope

Art of Brilliance

Dr Andy Cope describes himself as a qualified teacher, author, happiness expert and recovering academic. Andy’s Loughborough University PhD was 12 years in the making and while he appreciates that his ‘Dr of Happiness’ label is terribly cheesy it does afford him an important media platform. In times of rising depression and an epidemic of ‘busyness’, Andy believes there has never been a more appropriate time to raise the wellbeing agenda. Andy is lucky enough to work with some very large businesses, including Microsoft, DHL, Kellogg, Hewlett Packard, Astra Zeneca and Marriott Hotels. Recently, he has tailored his workshops to meet the needs of children and teachers and now delivers to audiences from age 8 upwards! Andy is also a best-selling author. ‘The Art of Being Brilliant’, ‘Shine’, ‘The Little Book of Emotional Intelligence’ and ‘Leadership: The Multiplier Effect’ have all been best-sellers. ‘Happiness Route Map’ was nominated as The Independent’s best self-help book of 2018. In an attempt to bring the messages to a younger audience Andy has also penned ‘The Art of Being a Brilliant Teenager’ and ‘Diary of a Brilliant Kid’. ‘The Little Book of Being Brilliant’ is scheduled for release in Spring 2019. Andy is a sought-after keynote speaker and authority on employee engagement, wellbeing and human flourishing. He’s done numerous TV and radio appearances as well as being featured in The Telegraph, Daily Mail and Esquire. As for genuinely interesting asides, Andy is also a best-selling children’s author. His ‘Spy Dog’ series has sold in excess of a million copies worldwide (he bigs himself up by telling everyone he is world famous, if you’re 7) Andy was born in the same year that England won the football world cup, he has pet pigs and has set up the hugely successful 2%ers club, the UK’s first, foremost and...err...only society for happy people. His ambition is to be able to surf, brilliantly!

Invited Speakers

Professor Gary Evans

Chief Science Advisor, Ministry of Business, Innovation & Employment

Professor Gary Evans is employed by the Victoria University of Wellington ( and spends 80% of his time seconded to the Ministry of Business Innovation and Employment as their Chief Science Advisor and as head of the Science Leadership Team. Gary completed his undergraduate and PhD degrees at the University of Otago in 1991 specialising in Organic Synthesis. He then moved to the University of Oxford to carry out post-doctoral studies on the development of novel chiral auxiliaries. In 1993 he was one of the founding scientists of the University of Oxford spinout Oxford Asymmetry. He returned to NZ in 1994 as an inaugural NZ Science and Technology postdoctoral fellow hosted by Carbohydrate chemistry team led by Professor Furneaux. In 1997 Gary began his collaboration with Peter Tyler, Richard Furneaux and Vern Schramm which led to the invention of the nucleoside analogues Mundesine, Ulodesine, and Galidesivir all of which have entered into human clinical trials and Mundesine has been approved for use in Japan. Gary has published 85 peer reviewed publications, is an inventor on 12 granted US patents, and has an H index of 37. Professor Evans will be taking part of the Chief Scientist Panel at the Conference on Thursday 19th September. 

Janet Dibb-Leigh, FAIM

Janet was a professional research manager in the Australian university sector for over 25 years, serving as Director of Research for two universities before joining the University of South Australia as a senior research strategist and partnership broker.  Whilst Janet had substantial experience in developing and implementing policies, strategies and management frameworks to advance research and research training, her particular passion was building lasting, mutually rewarding relationships – between researchers (across disciplines and institutions) and with government, business and community organisations.  She also enjoyed connecting research to the community by serving on various government and industry advisory committees, multi-agency task forces and Cooperative Research Centre Boards. In 2013, Janet set up JDL Advisory and focused primarily on assisting universities in capability profiling to better understand their research strengths and capacity by theme, and in coaching senior academic and professional leaders in the development of thematic frameworks and strategies to build effective research collaborations within and outside the institution that have the potential to deliver important outcomes for society. From the beginning of her career as a research manager, Janet felt strongly the importance of building strong relationships with colleagues in other institutions and sectors, nationally and internationally.  She was Founding President of ARMS, helped lead the establishment of the International Network of Research Management Societies and co-convened the Inaugural INORMS Congress.  She has been an active mentor for research administrators and managers in Australia and the UK, is a Distinguished Faculty Emeritus of the Society of Research Administrators International, participated in several early international research management benchmarking studies and served on the International Editorial Advisory Committee of Research Global from its inception. Janet is now fully retired and enjoying life to the full with her husband Roger Leigh, dividing her time between Adelaide and Cambridge, and enjoying the chance to travel and visit many life friends she has made through ARMS and its sister societies.  She joyously became a grandmother in June! Janet will be taking part in The Great Debate - "Research Management is harder now than way back when..." at the Conference on Wednesday 18th September. 

Dr Ross McLennan

Director of Research and Innovation Services, University of South Australia

Dr. Ross McLennan is the Director of Research and Innovation Services at the University of South Australia. In this role, he leads teams that work collaboratively to support researchers in engaging with partners; finding and securing funding; fulfilling regulatory requirements; and other related activities. Ross is also the President Elect of ARMS. A native of the U.K., Ross has considerable international experience in setting up successful teams and enterprises in broad fields of research – in particular, in bringing together the expertise and needs of academia, industry, government and funding partners. Prior to relocating to Adelaide, Ross was based in Maastricht, Netherlands, where he worked as C.E.O. of Scannexus – a European Centre of Excellence that pools the expertise of an international group of technological, clinical and academic organisations.  Immediately prior to his role in the Netherlands, he played a significant part in the development of the Scottish Academic Health Sciences Collaboration – establishing networks and facilitating the development of strategic collaborative partnerships between the Scottish Medical School community, public sector funding agencies, and large pharmaceutical and biotechnology research companies. Ross, along with his wife, Emma, and two young children relocated to Adelaide in July 2015 – they are enjoying the outdoor lifestyle, exploring the region, and are (still) adapting to the climate! Dr McLennan will be taking part in The Great Debate - "Research Management is harder now than way back when..." and will also act as facilitator for the Chief Scientist Panel at the Conference. 

Dr Mark Hochman

ARMS Business Consultant, Australasian Research Management Society

Mark Hochman gained a PhD in science (geology) in 1991 and has been in research management for more than 25 years including a period of 20 years as Director of the Research and Innovation Services Office at the University of South Australia. He is a foundation member of the Australasian Research Management Society (ARMS) and served on the ARMS Executive for six years, including a period as President in 2007/2008. Mark currently works as a consultant in research management including development of research impact strategies, research strategy reviews and process improvement. As a consultant he has been Program Manager overseeing development of an accreditation program for ARMS which provides the foundation level learning and skills for those who are new in the research management profession. He also acted as Program Manager for a 2012 national pilot program in Australia examining the case study approach to assessing research impact. Since 2011 he has worked with 20 Australian universities conducting research management reviews of Research Offices, research policies and strategies. In 2014 Mark was awarded the inaugural Janet-Dibb-Leigh Award for distinguished service to the Australasian research management community. Mark will be taking part in The Great Debate - "Research Management is harder now than way back when..." at the Conference on Wednesday 18th September. 

Professor Pat Buckley

Dean of Graduate Studies, University of South Australia

Professor Pat Buckley is the Dean of Graduate Studies at the University of South Australia.  Previously, she was the Director of the Sansom Institute for Health Research and the Dean Research & Research Education in the Division of Health Sciences.  A biochemist-turned-physiologist, Pat has initiated and led many improvements in research training here and elsewhere.  At UniSA, she also leads researcher development across the university and works closely with staff to enhance and support their research capacity. As Dean, she is responsible for developing an excellent and supportive environment for supervisors and for candidates undertaking higher degrees by research, and in aligning the University’s research training programs with its strategy of doing research which is inspired by challenges and opportunities, partnered with end-users and communities, and underpinned by excellence. Professor Buckley will be taking part of the Deans of Graduate Research Panel at the Conference on Friday 20th September. 

Professor Joe Luca

Dean, Graduate Research School, Edith Cowan University

Professor Joe Luca is the Dean of the Graduate Research School at Edith Cowan University. His research focus is on developing quality doctoral programs encompassing supervisory practice and training programs, industry engagement, developing impact, online delivery, admission and administration processes, mobility, international collaboration, research climate, candidate support services, professional skills and career development. Professor Luca will be taking part of the Deans of Graduate Research Panel at the Conference on Friday 20th September. 

Dr Cathy Foley

CSIRO Chief Scientist

Dr Cathy Foley, CSIRO Chief Scientist, has made distinguished contributions to the understanding of superconducting materials and to the development of devices using superconductors to detect magnetic fields and locate valuable deposits of minerals. Dr Foley has made significant contributions to the scientific community as president of several scientific societies and as a member of committees such as PMSEIC giving advice to Government on scientific and technological matters.  Cathy was awarded the `Woman of the Year’ by the NSW Government in 2013 and the International IEEE Award for Continuing and Significant Contributions to Applied Superconductivity 2014. In 2015 was awarded the Clunies Ross Medal of the Australian Academy of Technological Science and Engineering and in 2016 the Australian Institute of Physics  Medal for Outstanding Service to Physics. As a leader in CSIRO, Cathy is working to help existing Australia to transform to be globally competitive by engaging with Australian researchers and to build new companies and enterprises to assist with the translation of research for economic prosperity. Dr Foley will be taking part of the Chief Scientist Panel at the Conference on Thursday 19th September.